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Modern neuraxial labor analgesia: options
for initiation, maintenance and drug selection
Most authors would agree that central neuraxial analgesia is the best
form to manage labor pain. When neuraxial analgesia is administered to
the parturient in labor, different management choices must be made by the
anesthetist: how will we initiate analgesia, how will analgesia be main-
tained, which local anesthetic will we use for neuraxial analgesia and
which adjuvant drugs will we combine? The present manuscript tries to re-
view the literature to answer these questions.
INITIATION OF NEURAXIAL ANALGESIA
Almost two decades have passed since French and American trialsevaluated the use of spinal opioids during labor and since Euro-
pean randomized trials compared conventional epidural analgesia with
combined spinal epidural (CSE) analgesia (1–3). CSE analgesia has
gained worldwide acceptance and is becoming increasingly popular as
the method of choice for labor pain relief (4–9). Obstetric anesthetists
are divided when questioned on the place of CSE in labor analgesia.
Whilst some authors feel it should be the technique of choice, others re-
serve CSE for certain indications (10–15). Recently, Simmons et al.
published a Cochrane review concluding that CSE offers little benefit
as compared to conventional epidural analgesia (16). However, the au-
thors of this meta-analysis did acknowledge that CSE produced faster
analgesia, resulted in less need for rescue analgesia and was associated
with less urinary retention. Apart from a slight increase in the incidence
of pruritus, these beneficial effects were not associated with more com-
plications. The three demonstrated benefits of CSE are sufficient to
promotes it’s use if the side-effect profile remains unaltered. Further-
more it must be stressed that this Cochrane review can be criticized.
Firstly, a number of well performed studies were excluded from analysis
because of uncertain reasons. Inclusion of these well performed studies
into the analysis might have affected the overall conclusions. Secondly,
a number of outcomes were not considered in the analysis such as
one-sided analgesia, epidural catheter reliability, anesthetist interven-
tion rate, local anesthetic consumption and the occurrence of fetal heart
abnormalities. Finally, very different types of CSE were used in the var-
ious studies. They were all considered to be a generic procedure and an-
alyzed combined.
Arguably the most obvious advantage of the CSE technique is the
rapid and spectacular onset of effective analgesia with minute concen-
trations of local anesthetics with or without adjuvant drugs (16). Con-
sistently, effective labor analgesia is accomplished within 4–6 minutes
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following intrathecal injection (1, 2, 17–29). Following
conventional epidural analgesia, initial analgesia is usu-
ally achieved between 15 and 25 minutes. Some detrac-
tors argue that conventional epidural analgesia provides
equally fast analgesia (23). It is important to note, how-
ever, that although the onset time of epidural analgesia
might be reasonable, the reported values are means.
With epidural analgesia a wide inter-patient variability
exists depending on parity, stage of labor and other rele-
vant obstetric and non-obstetrical factors. Especially dur-
ing late labor, analgesia following an epidural injection is
often delayed and only successful if large doses are ad-
ministered. With CSE, onset time is short in all patients.
Several trials demonstrated lower VAS scores for labor
pain with CSE as compared to epidural analgesia (18,
30–32). However, other comparative trials could not de-
monstrate a difference in VAS scores for pain (23, 33, 34).
No trials report higher VAS scores with CSE. Most likely
especially during the first 30 to 60 minutes VAS scores are
lower when patients are treated with CSE.
Most anesthesiologists would agree that CSE pro-
vides better quality analgesia throughout the course of
labor (35). Vernis and co-workers demonstrated that less
patients reported unilateral analgesia with CSE (29). In-
terestingly, Hess et al. investigated the factors associated
with breakthrough pain during neuraxial labor analgesia
and found that patients treated with conventional epi-
dural analgesia were three times as likely to experience
recurrent breakthrough pain as compared to CSE treated
women (36). In contrast however, Goodman et al. in a
prospective study noted that additional top-ups to treat
breakthrough pain were requested by similar numbers of
patients irrespective of the analgesic strategy used (37).
The presence of a dural puncture may facilitate the
passage of epidurally administered drugs during mainte-
nance of analgesia to the cerebrospinal fluid. At least in
animals such an effect has been reported (38). In pa-
tients, Leighton et al. also reported that epidural bupi-
vacaine blocked more dermatomes when administered
following an initial dural puncture as compared to epidural
bupivacaine administered without prior dural puncture
(39). Leighton et al. used a 24 and 27G spinal needle.
Cappiello and co-workers performed a randomized,
double-blind study in which the dura was perforated
with a 25G Whitacre needle without administration of
spinal drugs (40). The control group had no dural punc-
ture. Patients treated with a dural puncture had better sa-
cral spread, shorter onset of analgesia and better quality
pain relief. Thomas et al. performed a similar study using
a 27G Whitacre needle and could not find a difference
between patients treated with or without a dural punc-
ture (41). So spinal needle size may be important. Many
studies report higher patient satisfaction with CSE (18,
19, 27, 42), while no studies report on the opposite.
Despite similar or improved quality of analgesia, local
anesthetic requirements are significantly reduced with
CSE (18, 19, 27, 29). Discussion remains whether this is
the result of the omission of the initial epidural bolus or
that also during labor a dose sparing effect persists. The
presence of the dural whole and the facilitated passage of
epidurally administered local anesthetics could offer part
of the explanation.
Following initial spinal analgesia, bilateral analgesia
and sensory changes occur, making testing of the epidu-
ral catheter difficult. The epidural catheter cannot prove
itself and many may question the reliability of the cathe-
ter to achieve bilateral analgesia once the spinal dose is
worn off. However various investigators noted that the
reliability of epidural catheters following CSE was sig-
nificantly increased as compared to stand alone epidural
catheters (40, 41, 43–48) (Table 1). There was less need
for epidural catheter replacement and there was less uni-
lateral analgesia requiring catheter manipulation. Lee et
al. reported less catheter failure when topping up for Ce-
sarean section when the catheter was placed as part of a
CSE technique of labor analgesia (44).
When using a CSE technique, a perfect midline ap-
proach is required to identify the subarachnoid space
and consequently more epidural catheters reliably are
positioned into the epidural space (48). Thomas et al. in-
terestingly noted that when no cerebrospinal fluid was
obtained following attempted CSE, subsequently much
more epidural catheters required replacement as com-
pared to those catheters placed when cerebrospinal fluid
was noted (41).
The CSE technique may have more complications.
What does the literature tells us? Pruritus is the most
common side effect of intrathecal opioids, occurring in
almost all patients, if directly questioned (18, 27, 29, 45).
In the most recent Cochrane review, pruritus was more
frequent following CSE and was reported to be the on-
line complication occurring more frequent as compared
with conventional epidural analgesia (16). It usually de-
velops shortly after analgesia. It is mild and hardly ever
requires antipruritic therapy. Since patients hardly ever
require therapy and seldom report pruritus as a reason
for dissatisfaction, pruritus is no reason to refrain from
using CSE and intrathecal opioids.
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TABLE 1
Reliability of epidural catheters: % of failed epidural cathe-
ters not producing adequate analgesia and that were
resited.
CSE Epidural
Norris 2000 (46) 0.2 % 1.3 %
COMET 2001 (43) 4.0 % 6.8 %
Van de Velde 2001 (48) 1.49 % 3.18 %
Thomas 2005 (41) 9.3 % 8.0 %*
Cappiello 2008 (40) 3 % 13 %
Lee 2009 (44) 1 % 6 %
Miro 2008 (45) 3.4 % 6.2 %
* Thomas et al. reported more catheter replacement when the
spinal component failed (22.2%).
Nausea and vomiting are very rare complications dur-
ing CSE and conventional epidural analgesia. No differ-
ences in the incidence of nausea have between reported
when comparing the two techniques, except in the retro-
spective trial by Miro et al. who reported more nausea
and vomiting in patients treated with epidural analgesia
(45). We must remember that nausea is a part of the birth
process especially during induced labour.
Both CSE and conventional epidural analgesia have
been associated with usually mild hypotension, which is
easily treated (49). Hypotension following the spinal in-
jection is transient and occurs within the first 30 minutes
following initiation of analgesia (29, 50, 51). In clinical,
routine practice it is important to avoid the supine posi-
tion. We always keep our patients in the completely left
lateral decubitus position to avoid any effect of aortacaval
compression.
Although opioids do not produce sympatholysis, hy-
potension is observed with pure intrathecal opioid anal-
gesia (52-55). When local anaesthetics are combined,
hypotension seems to be more pronounced, but clinically
usually easily treated (54). Intrathecal clonidine, how-
ever, is often associated with severe hypotension and this
author can not recommend it’s routine use based on his
personal experience with this drug. Hypotension can be
severe and is often protracted requiring prolonged sup-
portive vasopressor therapy (56, 57).
Respiratory depression is a recognized complication
of intrathecal opioids during labor, probably as a result of
rostral spread. Several case reports have demonstrated
that lipid soluble opioids may induce this potentially life
threatening complication (21, 58-65). In some, but not
all, cases respiratory arrest occurred in relatively short
stature women who had received parenteral or epidural
opioids prior to the spinal injection. Fortunately, respira-
tory depression occurred typically within the first 30
minutes and was easily treated and reversed using nal-
oxone. In one patient chest compressions and resuscita-
tion was required (65). Ferrouz et al. performed a retro-
spective chart analysis and reported 1 respiratory arrest
in over 5000 CSE performed with 10 mg spinal sufentanil
(59). As this complication is rare, most authors advocate
vigilance and advise to use lower doses of intrathecal
opioids then those initially used on empirical grounds
(66). Other complications related to excessive rostral
spread of opioids and local anaesthetics have been de-
scribed and include: aphonia, aphagia, dysphagia, al-
tered levels of consciousness, high sensory block, tran-
sient swallowin difficulties, etc… (67–72). Also sudden
hypoglycemia has been described (73, 74).
Some authorities claim that the risk of central nervous
system infections is increased secondary to the breach of
the dura (75). However, Camann and Birnbach both
agree that at the moment there is no scientific evidence
indicating that CSE analgesia is associated with more in-
fectious problems than epidural analgesia (76, 77). In-
deed several case reports of meningitis or epidural ab-
scess have been reported following CSE anesthesia in
obstetric patients (29, 78–82), but also with simple spinal
anesthesia and conventional epidural techniques central
nervous system infections have been reported (83–86).
Despite these occasional case reports, CNS infections re-
main extremely rare irrespective of the neuraxial tech-
nique used. Six publications evaluate the risk of infec-
tions following neuraxial anesthesia in obstetric patients
(66, 87–91). In over 900.000 patients only 2 cases of
epidural abscess and 3 cases of meningitis were reported.
Most authors, however, agree that strict aseptic tech-
niques are of vital importance to prevent serious infec-
tions.
Several case reports in pregnant women of damage to
the conus medullaris have been reported when using
CSE (92). Especially with CSE it is imperative to perform
the block as low as possible since the conus medullaris
might extend below the L2 vertebral body. Up to 5% of
parturients can have a conus which extends lower than
the L2 vertebral body (93). To avoid conus damage, care-
ful attention to the correct interspace is required. It has
been clearly demonstrated, using radiography and ultra-
sound, that most anesthetists, using anatomical land-
marks, are 1 to 4 interspaces away from where they think
to be (93, 94). Identification of the correct interspace is
therefore of prime importance. Ultrasound may be use-
ful, especially in obese patients, to indetify or confirm the
correct interspace (93).
Since CSE includes a dural puncture, there is a theo-
retical risk of postdural puncture headache (PDPH).
This is a devastating complication in an otherwise healthy
mother, keen on taking care for her newborn child. How-
ever the use of small-gauge atraumatic spinal needles
(26–29 G) has dramatically decreased the problem. From
the available literature it seems that PDPH occurs in no
more than 1% of patients. Furthermore the incidence is
not increased as compared to conventional epidural an-
algesia (18, 29, 35, 42, 43, 45, 47, 49, 53, 76, 95, 96). Norris
et al. reported that unintended dural puncture with the
epidural needle occurs much more frequent when using
conventional epidural analgesia as compared to CSE
(49) Rarely the spinal needle itself is responsible for
PDPH. Usually a dural tap with either the Tuohy needle
or the epidural catheter causes postural headache. It is
also worthwhile to mention several reports advising to
insert the epidural catheter in the subarachnoid space
following an accidental dural tap. The incidence of PDPH
and bloodpatching seems reduced when the epidural
catheter is threaded intrathecally (96–100). Of interest is
that air should be replaced by saline in the loss of resis-
tance technique, as air might cause more PDPH, in-
crease it’s severity and induce other problems with your
epidural block such as recurrent breakthrough pain (101,
102).
For many years, strategies to reduce the incidence and
severity of motor block, associated with epidural analge-
sia, have been designed. Lower concentrations of local
anesthetic solutions, the addition of opioids and other
adjuvant drugs, the introduction of patient controlled
epidural analgesia and the use of newer local anesthetic
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agents have been instrumental in reducing problematic
motor block. Low dose epidurals are successfully used to
allow laboring women to maintain mobility whilst being
completely pain free (19, 95). With CSE it is easier to
provide effective analgesia with no or very minute doses
of local anesthetics. As already described, CSE decreased
total local anesthetic consumption (18, 19, 27) and de-
creased the occurrence of motor block compared to stan-
dard epidural techniques (18, 19, 27, 95).
Some authors have questioned the safety of walking
during labor and neuraxial analgesia. However, several
authors demonstrated that with CSE motor function and
balance remained intact, whilst low dose epidurals in-
duced clinically detectable dorsal column deficits (82,
103, 104). Ambulation is become common practice and
can be advised, provided adequate precautions, written
protocols and testing of motor function following initia-
tion of analgesia is performed. Motor function testing is
straightforward and includes the ability to perform a
deep knee bend unassisted and to perform a straight leg
lift for 30 seconds with the eyes closed. Caution is re-
quired when using epidural test doses following inser-
tion of an epidural catheter, since test doses can signifi-
cantly impair motor strength (105). Controversy also
exists on the effects of spinally administered epinephrine
(28, 106) on motor block. Whilst minute doses do not im-
pair motor function, larger doses have a significant im-
pact (64, 106).
Epidural analgesia has been implicated in prolonged
labors, an increased instrumental delivery rate and an in-
creased Cesarean section rate. Extensive research has
now led to unanimous consensus that epidural analgesia
does not produce more instrumental vaginal and opera-
tive deliveries. However, epidural analgesia prolongs the
duration of the first stage of labor and increases the need
for exogenous oxytocin. Tsen et al. demonstrated in a
prospective, randomized trial that CSE is associated
with an increased cervical dilation rate (107). Patients
randomized to CSE analgesia experienced a doubling of
the mean cervical dilation rate and a reduced duration of
the first stage of labor as compared to epidural analgesia
(107). Disappointingly, several randomized trials com-
paring CSE with conventional epidural analgesia could
not demonstrate a difference in labor duration (19, 26,
27, 47). CSE as compared with low dose epidural strate-
gies was not associated with an increased spontaneous
vaginal delivery rate in most trials (7, 18, 19, 26, 33, 42,
47). Only one trial reported less instrumental vaginal de-
liveries with CSE as compared to epidural analgesia
(95).
Abnormal fetal heart rate recordings and fetal brady-
cardia are worrisome side effects that may follow any
type of effective labor analgesia. Some authors reported
that this complication could be more common following
intrathecal opioids than following conventional epidural
analgesia (108–111). Clarke et al. were the first to de-
scribe in detail the association between intrathecal
opioids, uterine hyperactivity and fetal bradycardia in the
absence of maternal hypotension (108). Since then sev-
eral non-randomized trials have evaluated the incidence
of fetal heart rate changes following either intrathecal
opioids and conventional epidural analgesia (48, 112–
114). Nielsen et al. and Eberle et al. did not observe an
increased incidence of fetal heart rate abnormalities,
whilst all other non-randomised reports noted at least a
doubling of the incidence of worrisome fetal heart rate
changes.
Mardirossof et al. performed a meta analysis of several
prospective trials comparing intrathecal opioid analgesia
with non-intrathecal opioid analgesia with respect to fe-
tal bradycardia (115). These authors concluded that in-
trathecal opioids were associated with significantly more
fetal heart rate abnormalities. Vercauteren suggested that
the incidence of fetal bradycardia depended on the dose
of the intrathecal opioid (116). Van de Velde et al. con-
cluded that high doses of intrathecal opioids increased
the incidence of fetal heart rate abnormalities despite a
reduced incidence of hypotension (27). Similar results
were published by Nicolet et al. (117). These authors also
indicated that older age and higher VAS scores prior to
analgesia were risk factors associated with fetal heart rate
abnormalities after CSE. Gaiser suggested that the risk
of abnormalities in the fetal heart rate is increased when
the fetal head is not engaged or when decelerations are
already present prior to initiation of analgesia (118).
The presumed mechanism of opioid induced non-re-
assuring fetal heart rate tracings is uterine hyperactivity
caused by rapid analgesia and as a result a rapid decrease
in maternal circulating cathecholamines. Abrao et al. re-
cently measured uterine tone using an intrauterine
epressure catheter following either CSE or conventional
epidural analgesia (119). Fetal heart rate changes and
uterine hypertonus occurred more frequently following
CSE. Analgesia was initiated rather late in labor and un-
fortunately these authors only measured intrauterine
tone and fetal heart rate for 15 minutes after initiation of
analgesia. So changes associated with epidural analgesia
might have been missed. They also demonstrated that
the faster analgesia occurred and the more pronounced it
was, the higher the probability of abnormal cardiotoco-
graphic readings. Of course this effect is strengthened by
the simultaneous occurrence of maternal hypotension in
certain patients.
It is important to note that neonatal and obstetric out-
come is not affected by the use of intrathecal opioids.
Carvalho et al. failed to demonstrate any changes in fetal
oxygen saturation following CSE analgesia (119). In
none of the reports emergent C-sections had to be per-
formed as a result of sufentanil induced non-reassuring
fetal heart rate tracings (27, 28, 112, 113, 114, 115, 118,
120, 121). Also neonatal outcome, as assessed by Apgar
scores, umbilical artery pH and admittance to the neona-
tal intensive care, was unaffected by the technique used.
Albright and Forster performed an institutional retro-
spective survey involving 2500 patient records and ob-
served no increase in emergency Cesarean delivery asso-
ciated to the use of intrathecal opioids (122). Only
Gambling et al. contradicted this and reported an in-
174 Period biol, Vol 111, No 2, 2009.
M. van de Velde Modern neuraxial labor analgesia
creased C-section rate due to more non-reassuring fetal
heart rate abnormalities (123). However also in their
study neonatal outcome was good and not different from
the epidural group.
Since epidural catheters can inadvertently be mis-
placed in either the cerebrospinal fluid or in an epidural
vein, anesthetists have been using test doses to verify the
correct position of the catheter. Unfortunately, test doses
are neither sensitive nor specific (124, 125). Furthermore
epinephrine containing test doses can induce motor im-
pairment and thus complicate ambulation during labor
(105). Some authors also suggested that an epinephrine
containing test dose has potential adverse effects on ute-
roplacental perfusion (126). As a result several authors
suggested to abandon routine testing of the epidural
catheter, since adequate analgesia confirms the correct
position of the catheter without prior testing (127).
With CSE, analgesia occurs rapidly and testing the
functionality of the epidural catheter is not possible until
the initial spinal dose wears off. Many authors consider
the fact that the reliability of the epidural catheter is un-
certain during this period as a major disadvantage. Their
concern is related to the possibility that the catheter may
be dysfunctional when an emergency cesarean section is
required. Especially in high risk pregnancies this is con-
sidered a major drawback. However, it is important to
note that even with a well tested epidural catheter, we can
never be absolutely sure that several hours later the cath-
eter remains correctly positioned. Even with conven-
tional epidural catheters fractioned dosing or a de novo
test dose are required the moment the catheter is used for
the injection of high doses of local anesthetics.
A second concern involves the fact that some authors
do not want to initiate epidural analgesia immediately
after the spinal dose. Only when the epidural catheter is
formally tested once the spinal dose has worn off, the
catheter is used throughout labor. As a result most pa-
tients will experience breakthrough pain. However, sev-
eral authors initiate an epidural infusion immediately
following the initial spinal dose. With low volume, low
dose techniques, the risk of total spinal anesthesia or
toxic side effects is minimal. These doses cannot produce
systemic toxicity or total spinal anesthesia even when di-
rect intravascular or intrathecal injection occurs. How-
ever if a continuous epidural infusion or patient con-
trolled epidural analgesia does not produce adequate
analgesia, one must consider an intravascular position of
the catheter.
Currently, a local anesthetic (bupivacaine, ropivacaine
or levobupivacaine)/opioid (fentanyl/sufentanil) mixture
is used to initiate spinal anesthesia. Van de Velde et al.
were the first to construct the full dose response relation-
ship of spinal ropivacaine, levobupivacaine and bupi-
vacaine combined with opioids for labor analgesia (128).
These investigators noted that bupivacaine was signifi-
cantly more potent then both other local anesthetics and
that ropivacaine and levobupivacaine were of similar po-
tency (128). They also noted that in active labor much
more local anesthetic was required then previously de-
scribed on empirical grounds to produced affective
analgesia in all parturients.
Several authors have suggested to prolong initial in-
trathecal analgesia by the addition of various other drugs
such as clonidine, epinephrine and neostigmine. Although
these drugs were succesfull in prolonging analgesia, they
also produced significantly more side-effects.
MAINTENANCE OF ANALGESIA
Maintenance of analgesia can be achieved using ei-
ther intermittent top-ups (ITU), continuous epidural in-
fusions (CEI) or patient controlled epidural analgesia
(PCEA) with or without a background infusion. In Cali-
fornia, only 25% of obstetric anaesthesia units used PCEA
in 2005 (129). In the United Kingdom only 5% of units
used PCEA in 1999 (130). However in Belgium in 2005,
the majority of hospitals used PCEA (131).
The pros and cons of ITU, CEI and PCEA by com-
paring them to each other will be reviewed. We will eval-
uate quality of analgesia and incidence of unwanted
side-effects of analgesia according to the mode of main-
taining analgesia.
Intermittent top-ups versus continuous
infusion
The administration of intermittent top-ups is histori-
cally the first modality with which epidural analgesia
was maintained. Anaesthetists or midwifes administer a
bolus of local anaesthetic solution either on patient re-
quest or after a fixed interval. Several potential problems
however may arise. Administration of large doses of local
anaesthetic in bolus can lead to systemic toxicity. Fur-
thermore bolus administration may elicit maternal
hypotension and fetal heart rate abnormalities. Addi-
tionally, ITU can lead to periods of inadequate pain con-
trol. As a result investigators tried to improve epidural
analgesia by developing CEI.
Lamont et al. demonstrated that ITU are indeed asso-
ciated with more additional top-ups, that hypotensive
episodes are more frequent, that fetal heart rate changes
occur with a higher frequency, that more babies require
admission to the neonatal care unit and that quality of
analgesia is less then with CEI (132). Also D’Athis et al.
showed that CEI is associated with better analgesia and
less local anaesthetic consumption (133). However many
studies reported no differences in terms of analgesic quali-
ty between ITU and CEI (133–135), and some reported
that ITU was associated with better analgesia (136–137).
Most studies also showed that local anaesthetic consump-
tion is reduced with ITU (133, 134, 136, 137). Despite less
anaesthetic consumption, obstetric outcome is usually
similar between the two modalities (135–140), except for
more spontaneous deliveries with ITU in the study by
Smedstad et al. (134). So basically, CEI and ITU are
quite similar in terms of quality of analgesia and inci-
dence of side-effects with a tendency towards better per-
formance for the ITU technique.
Period biol, Vol 111, No 2, 2009. 175
Modern neuraxial labor analgesia M. van de Velde
Patient controlled epidural analgesia
(PCEA) versus intermittent top-ups
Several studies compared PCEA with ITU techniques
of maintaining epidural analgesia during labour (135,
137, 140–144). Quality of pain relief was similar between
the two modalities, except in the study by Paech et al.
(143): ITU resulted in higher maximal pain scores. Also
in the study by Halonen et al. PCEA produced better an-
algesia (141). Gambling et al. reported increased satisfac-
tion scores with PCEA as compared to ITU, but other
authors could not confirm these results (144). In terms of
local anaesthetic consumption reported results are con-
flicting: most studies show no difference, while some re-
port an increased consumption with PCEA and others
report a decreased consumption with PCEA (137,
141–143). Two studies demonstrate a negative effect on
obstetric outcome with PCEA (141, 143). Paech et al. ob-
served a prolonged second stage of labour, while Halo-
nen et al. noted more Caesarean sections as well as a lon-
ger second stage (141, 143).
Patient controlled epidural analgesia
(PCEA) versus continuous epidural
infusions (CEI)
Numerous studies have evaluated PCEA since it’s in-
troduction into obstetric analgesia in 1988 by Gambling
et al. (145). PCEA produced similar levels of pain relief
in most studies in terms of recorded Visual Analogue
Scores for pain (135, 137, 140, 145–155). However, qual-
ity of pain relief is more than recorded VAS scores. One
important parameter is the incidence of breakthrough
pain requiring medical staff (anaesthetist) intervention.
Although theoretically CEI may require fewer anaesthe-
tist interventions, most studies indicate that just the op-
posite is true. PCEA is associated with less medical staff
interventions. This was clearly demonstrated by an excel-
lent meta-analysis by van der Vyver et al. comparing PCEA
with CEI (156). Some studies also showed that patient
satisfaction was increased with the PCEA modality
(147). Patient satisfaction is increased because of in-
creased patient responsibility, patient control of labour
experience, patient titration to the desired level of pain
and a considerable placebo effect by pressing the PCEA
button.
PCEA is also associated with significantly less local
anaesthetic consumption (156). Reductions vary from
study to study between 20% less to 55% less local anaes-
thetic consumption. As a result significantly less motor
block is observed with PCEA (156). It remains unclear
whether this results in a better obstetric outcome. Most
studies can not identify a difference between both modal-
ities. However, some indicate less outlet forceps deliveries
may be required when using PCEA (148, 253, 154). The
meta-analysis by van der Vyver et al. could not confirm
this however (156).
The use of background infusions combined with a
PCEA modality is controversial. Some authors indicate
that a background infusion confers no benefit while oth-
ers suggest better pain scores with a background infusion
(157–159). However the difference may be that a back-
ground infusion seems particularly useful when analge-
sia is initiated with CSE. The background infusion en-
sures epidural priming when the patient requests the
first epidural bolus. When the epidural space is primed
more rapid and more effective analgesia is most likely ob-
tained (158, 159, 160).
In recent years several authors have evaluated the use
of PCEA combined with automated intermittent bolu-
ses. Both Wong et al. and Sia et al. compared automated
boluses with continuous background infusion both com-
bined with PCEA (161, 162). In both studies automated
boluses performed better resulting in less local anaes-
thetic consumption, less clinician intervention and bet-
ter quality of pain relief. Now, several studies are emerg-
ing looking at computer integrated PCEA. Computer
integrated PCEA is a conventional PCEA system but
with an automated feedback loop: the rate of a continu-
ous background infusion is adapted according to the ad-
ministered PCEA boluses during the previous hour (163).
Computer integrated PCEA resulted in less breakthrough
pain and higher parturient satisfaction.
CONCLUSION
Based on the literature, PCEA and ITU seem to be
superior options compared to CEI for maintenance of la-
bour analgesia. Both modalities result in less local anaes-
thetic consumption, less motor block and increased pa-
tient satisfaction as compared to CEI. PCEA may be
slightly more expensive then ITU, but results in far less
medical staff workload. Depending on local legislation,
ITU may not be an option. PCEA with a background in-
fusion, especially when CSE is used, may be a good op-
tion. However te background infusion rate should be
small (no more than 25% of total hourly consumption).
New PCEA modalities are being developed.
Choice of local anesthetic
Bupivacaine is worldwide probably the most com-
monly used drug for obstetric regional anaesthesia and
analgesia. Reports of bupivacaine cardiotoxicity after un-
intentional intravascular injection mainly in obstetric
patients have led to the development of ropivacaine and
levobupivacaine (164). These drugs appear to be safer al-
ternatives as compared to bupivacaine. These drugs also
have a greater separation between sensory and motor
blockade, an especially advantageous feature during la-
bour analgesia. Since these drugs were marketed, the
pharmaceutical industry is pushing anaesthetists to
change their practice in favour of these new local anaes-
thetic agents. Is this the correct strategy to follow? What
is the place of racemic bupivacaine in modern obstetric
analgesia?
Risk of systemic toxicity
All local anaesthetics can produce systemic toxicity by
direct and indirect mechanisms that derive from their
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mode of local anaesthetic actions, i.e. inhibition of volt-
age-gated ion channels (165, 166). Furthermore local an-
aesthetics also interfere with mitochondrial respiration
by impeding oxidative phosphorylation, thus depleting
the cell’s energy reserve. Ropivacaine and levobupivaca-
ine both have lower systemic toxicity then bupivacaine
(165–167). Ropivacaine seems to be the least toxic, levo-
bupivacaine has intermediate toxicity and bupivacaine is
most toxic. Evidence comes from numerous in vitro cel-
lular studies, ex vivo whole organ studies, whole body
studies in animals, whole body studies in human volun-
teers and case reports. Reduced systemic toxicity has also
been demonstrated in pregnant animals (168).
Caution remains essential in using large volumes or
doses of local anaesthetic. These new local anaesthetics
should not be regarded as “safe” but as “safer” alterna-
tives to bupivacaine. It remains essential that clinicians
use the customary precautions to minimize the risk of
systemic toxicity e.g. standard monitoring, aspiration of
the catheter prior to injection of local anaesthetics, use of
a test dose, fractionation of the injected dose and use of
the lowest local anaesthetic concentration feasible.
Excellent labour analgesia with minimal
side-effects
One of the factors implicated in the association be-
tween epidural analgesia and increased rates of operative
delivery is motor block from epidural local anaesthetic.
Motor block can be minimized by reducing the concen-
tration of local anaesthetic, by decreasing the total dose
used or by choosing a local anaesthetic with a high differ-
ential sensory:motor block ratio.
Several trials have evaluated conventional labour an-
algesia using rather high concentrations of different local
anaesthetics ( 0.2%). A meta-analysis of six trials com-
pared 0.25% of ropivacaine with 0.25% bupivacaine. A
total of 391 patients were analysed. The authors con-
cluded that ropivacaine produced less motor block, re-
sulted in a higher spontaneous vaginal delivery rate and
had less effects on the neurological adaptive capacity
scores (NACS) of the neonates (169). Asik et al. pro-
duced similar results comparing 0.2% ropivacaine and
bupivacaine solutions combined with fentanyl for epi-
dural labour analgesia: less motor block and more spon-
taneous vaginal deliveries were noted (170).
However, modern labour analgesia uses far lower con-
centrations of local anaesthetics. The advantages in terms
of motor block and labour outcome of lower epidural lo-
cal anaesthetic concentrations were well demonstrated
by the COMET trial (171). Halpern and Walsh per-
formed a meta-analysis of 23 randomised trials that com-
pared ropivacaine and bupivacaine during labour anal-
gesia (172). Onset, duration and quality of analgesia
were perfectly comparable between the two local anaes-
thetics. No differences in mode of delivery or other out-
come parameters were identified, except for a more fre-
quent incidence of motor block with bupivacaine. The
results related to motor block were not combined statisti-
cally because of the large amount of heterogeneity among
studies resulting from the large differences in drug doses
and concentrations used among studies. If one outcome
parameter, however, is not evaluated statistically because
differences in methodology among studies, why then
compare other outcome parameters despite these meth-
odological differences among studies?
Several individual studies using low concentrations of
local anaesthetic ( 0.125%) however did demonstrate dif-
ferences in motor block with ropivacaine producing less
motor block then bupivacaine (173–181). Gautier et al.
clearly demonstrated that, especially if the cumulative
epidural dose of local anaesthetic increased, the risk of
motor block was increased with bupivacaine (175). This
difference persisted if lower concentrations of epidural
bupivacaine were used to provide analgesia. Table 1 gives
an overview of motor block reported in several studies that
compared low and similar concentrations of ropivacaine
and bupivacaine during labour analgesia. Combined, it
becomes clear that motor block occurs much less with
ropivacaine. Atienzar demonstrated that both ropivacaine
and levobupivacaine produced less motor block (177).
This has been recently confirmed using the MLAC
methodology. Lacassie et al. determined the motor block
MLAC concentration of ropivacaine and bupivacaine
using a model of up-and-down sequential allocation
(182). These authors noted that ropivacaine was signifi-
cantly less potent for motor block then bupivacaine, at
66% that of bupivacaine.
Similar observations can be made for intrathecal ropi-
vacaine and bupivacaine. Excellent analgesia is achieved
with both agents using similar spinal doses but with less
motor impairment in patients treated with ropivacaine.
Table 2 gives an overview of the number of patients devel-
oping detectable motor block in various studies that com-
pare intrathecal ropivacaine and bupivacaine (183–186).
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TABLE 1
Number of patients with motor block in bupivacaine or ro-
pivacaine treated patients using similar and low ( 0.125%)








Campbell et al. (173) 5 0* 40
Meister et al. (174) 18 8* 50
Gautier et al. (175) 15 3* 90
Lee et al. (176) 21 10 346
Owen et al. (178) 12 8 50
Gogarten et al. (179) 11 4 109
Chua et al. (180) 5 3 32
Fischer et al. (181) 19 10 189
Atienzar et al. (177) 18 13 65
TOTAL 124 59 971
For levobupivacaine less information is available.
Lacassie et al. determined the motor block MLAC con-
centration of levobupivacaine and bupivacaine using a
model of up-and-down sequential allocation (187).
These authors noted that levobupivacaine was signifi-
cantly less potent for motor block then bupivacaine, at
87% that of bupivacaine. Vercauteren et al. observed no
clinical differences between spinal levobupivacaine and
racemic bupivacaine except for less motor block with
levobupivacaine (188).
The clinical relevance of reduced
potency
So-called MLAC studies have repetitively demon-
strated that ropivacaine and levobupivacaine are less po-
tent during labour analgesia at the ED50 point of the
dose-response curve then bupivacaine (189–191). Al-
though MLAC studies have undoubtedly added to our
understanding of local anaesthetics and their relative po-
tency, there are several caveats when applying these re-
sults to the clinical situation of labour analgesia. First,
MLAC studies only focus on one point of the dose re-
sponse curve and provide no information on the slopes of
the different dose response curves. Second, MLAC stud-
ies only focus on the concentration used and not on the
total dose. However total dose, determines the intensity
of sensory and motor block (192). Third, it is difficult to
control for confounding factors such as stage of labour,
parity, type of labour, etc…, factors that each individually
impact on labour pain intensity. Fourth, MLAC studies
determine relative potency for initiation of analgesia
during labour, but do not provide information on relative
potency during maintenance of analgesia (which might
be influenced by factors such as local anaesthetic lipid
solubility or effects of local anaesthetics on epidural
vasculature). However, despite these criticism, most cli-
nicians would agree that new local anaesthetics are in-
deed less potent then bupivacaine. Recently this has been
confirmed by the first full dose response comparison of
levobupivacaine, ropivacaine and bupivacaine, used for
spinal labour analgesia (193). Other authors did propose
a potency hierarchy: bupivacaine > levobupivacaine >
ropivacaine (186).
Clinicians live, however, in the real world. Most of us
are not interested in the ED50, but want all are patients
to be without pain. This means we will overdose some
patients, to achieve good analgesia for all. Various solu-
tions to minimize overdosing have been successfully in-
vestigated such as patient controlled epidural analgesia
(PCEA). It is this authors conviction that the new local
anaesthetics contribute to minimizing the side-effects of
systematic overdosing, which is unavoidable in many pa-
tients.
CONCLUSION
Ropivacaine and levobupivacaine are safer drugs, have
less prolonged motor block following Caesarean section,
demonstrate greater motor-sensory separation during la-
bour analgesia, and result in better neonatal and labour
outcome when higher concentrations of local anaesthetics
are used throughout labour. Unfortunately until now no
study could identify improved labor outcome with low
concentrations of the new local anaesthetics. We feel that
the slightly increased cost is justified by the advantages in
terms of safety and motor block and we are convinced that
every institution should replace bupivacaine by one of its
newer alternatives, as have done we!
Adjuvant drugs
Different adjuvant drugs have been tested for use in
neuraxial labour analgesia: opioids, clonidine, neostig-
mine, epinephrine, magnesium and adenosine.
Opioids
Opioids used for labour pain relief act through mech-
anisms in the dorsal horn. Activation of m, d and k- recep-
tors induces pre-synaptic inhibition of neurotransmitter
release and produces post-synaptic neuronal membrane
hyperpolarisation.
Pure epidural opioid analgesia is feasible in the early
stages of labour. Capogna et al. determined the ED50 of
epidural fentanyl and sufentanil using the MLAC meth-
odology (194). To produce analgesia in 50% of patients a
dose of 124 µg fentanyl and 21 µg sufentanil was re-
quired, establishing a potency ratio of 5.9 between
sufentanil and fentanyl.
However, usually opioids are combined with local an-
aesthetics. It has been repeatedly shown that opioids
have a synergistic effect with various local anaesthetic
agents. Opioids reduce the ED50 of different local anaes-
thetics (195). In clinical practice the addition of opioids
reduces the onset of analgesia, prolongs the duration of
initial epidural analgesia, reduces local anaesthetic con-
sumption and decreases the incidence of patients with
insufficient analgesia (196). The incidence of trouble-
some motor block is reduced and the rate of spontaneous
vaginal delivery is increased (196). Unfortunately, more
patients experience pruritus (196).
Plain intrathecal opioids are successful in producing
labour analgesia. Palmer et al. established that fentanyl
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TABLE 2
Number of patients with motor block in bupivacaine or
ropivacaine treated patients using similar doses of local








Levin et al. (183) 0 0 48
Hughes et al. (184) 8 1* 40
Lim et al. (185) 5 2* 40
Camorcia et al. (186) 8 1 64
TOTAL 21 4 192
25 µg was the optimal intrathecal dose (197). Increasing
the dose above 25 µg did not improve the duration or
quality of analgesia, but increased the incidence of side
effects. For sufentanil an ED95 of 8.9 µg was established
(198). However, certainly in Europe, most anaesthesio-
logist prefer the intrathecal combination of local anaes-
thetics and opioids. Adding opioids to the spinal mixture,
reduces the ED50 of the local anaesthetic agent and pro-
longs dose-dependently the duration of initial spinal an-
algesia (199).
Respiratory depression following intrathecal opioids
has been described. This occurred usually in small pa-
tients receiving high doses of opioids following initial
parenteral opioid analgesia. Respiratory depression oc-
curred within 30 minutes from injection. Vigilance fol-
lowing the intrathecal injection of opioids is therefore re-
quired. During labour analgesia, intrathecal opioids have
been associated with new onset foetal heart rate changes
(27). Usually these changes were related to uterine hy-
peractivity and not maternal hypotension (27). Several
authors postulated that an imbalance between maternal
cathecholamines following rapid spinal analgesia pro-
duces uterine hypertonicity (27). It remains unclear why
this only occurs following high dose intrathecal opioids
and not following the combination of lower doses of
opioids and local anaesthetics (27).
Clonidine
Clonidine, an a2-receptor agonist, acts through a2-re-
ceptors located in the dorsal horn to produce labour anal-
gesia. Pre-synaptic stimulation of a2-receptors inhibits
neurotransmitter release and post-synaptic stimulation
prevents neuronal transmission through hyperpolarisa-
tion. Animal safety studies established that clonidine was
not neurotoxic and did not affect spinal cord blood flow
(200, 201).
A limited number of clinical trials have studied various
doses (30–150 µg) of epidural clonidine during labour.
Based on the MLAC methodology, a minimum of 60 µg
clonidine is required to reduce the ED50 of ropivacaine
for labour analgesia (202). Doses above 100 µg induce ma-
ternal hypotension, bradycardia and sedation and in some
trials also new onset foetal heart rate changes (203). Based
on a dose response study of Brichant et al. and recent work
by Landau et al. we conclude that the optimal epidural
dose of clonidine is probably 75 µg (204, 205). Prolonged
analgesia, reduced local anaesthetic consumption, less
epidural top-ups for breakthrough pain without an increase
in side effects were noted (204, 205).
Chiari et al. studied the use of pure spinal clonidine
labour analgesia (206). This seems not feasible since
doses producing adequate analgesia also induce unac-
ceptable side effects such hypotension. Adding lower
doses of clonidine (15–45 µg) to spinal analgesics does
improve the duration and quality of initial spinal analge-
sia (207, 208, 209). However, especially when clonidine
is combined with local anaesthetic agents, significant
and prolonged hypotension is likely to occur (208, 209).
Epinephrine
Epinephrine also acts through a2-receptors. However
vascular effects, especially with epidural administration
might also be involved.
Epidurally administered epinephrine significantly re-
duces the MLAC concentration of bupivacaine in la-
bouring patients and improves the quality of analgesia
(210). Also for spinal use epinephrine, combined with lo-
cal anaesthetics and opioids, has been evaluated in a
wide range of doses from 2.25–100 µg. Duration of in-
trathecal analgesia was consistently prolonged (211).
Unfortunately, epinephrine also induces an increased
incidence of maternal motor deficit especially when ad-
ministered epidurally or intrathecally (212, 213). Minute
doses (2.25 µg) of spinal epinephrine were not associated
with more motor block. Epidural epinephrine might also
prolong labour duration by ß-agonist effects, especially
when higher doses are infused in the epidural space
(212–216). Furthermore adding epinephrine to pharma-
cist pre-prepared solutions complicates storage and sig-
nificantly increases the price of handling and prepara-
tion. Thus, this author has abandoned the addition of
epinephrine from the local anaesthetic solution used for
spinal and epidural administration.
Neostigmine
Acetylcholine is an important neurotransmitter in the
dorsal horn of the spinal cord for the descending inhibi-
tory pathways. Neostigmine, a cholinesterase inhibitor,
increases the concentration of acetylcholine in the synap-
ses and thus stimulates analgesia by stimulating acetyl-
choline mediated mechanisms of analgesia. Naguib and
Yaksh demonstrated that the analgesic effects of neo-
stigmine and clonidine are synergistic (217). Following
reassuring safety studies, in which no neurotoxic effects
and no detrimental effects on spinal cord perfusion were
identified, neostigmine has been evaluated for labour
pain relief (218, 219).
Several trials evaluated the effects of epidural neostig-
mine (220, 221). Neostigmine seems to be promising as
an adjuvant drug for labour analgesia.
Nelson et al. investigated the analgesic potential and
side effect profile of 5, 10, 20 µg intrathecal neostigmine
alone (222). From this first phase, these investigators
chose 10 µg as the optimal dose to be added to intrathecal
sufentanil and determined the ED50 of spinal sufentanil
with and without neostigmine. Neostigmine successfully
reduced the ED50 of spinal sufentanil. In a further step,
they compared twice the ED50 of spinal sufentanil with
neostigmine to twice the ED50 of plain spinal sufentanil.
A synergistic effect on duration of analgesia of neostig-
mine was observed. D’Angelo et al. however reported no
increase in analgesic duration with neostigmine as part
of a multi-drug combination (local anaesthetic, opioid,
clonidine and neostigmine) (223). Furthermore several
authors reported a very high incidence of severe nausea
and vomiting (224).
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Other drugs: magnesium and adenosine
Both adenosine and magnesium have been added to
intrathecal opioids to relief labour pain (224, 225). No
significant advantages of adding adenosine to the anal-
gesic mixture were observed. Magnesium prolonged
intrathecal fentanyl analgesia.
Conclusion
Local anaesthetic agents combined with opioids re-
main the cornerstone of effective spinal and epidural la-
bour analgesia. Epidural clonidine is a valuable adjuvant
drug, especially in difficult to control labour pain. An
epidural dose of 75 µg seems safe and effective. Spinal
clonidine is effective but has been shown to induce diffi-
cult to control hypotension and should therefore be re-
served for very specific situations. Routine us cannot be
recommended by this author.
Epinephrine is a valuable drug but potential prob-
lems such as motor block, detrimental effects on the
progress of labour and storage problems limit its useful-
ness. With neostigmine limited clinical experience is
available. Spinal neostigmine produces unacceptable
nausea and vomiting. Adenosine and magnesium have
recently been studied during labour analgesia. Prelimi-
nary data are disappointing.
CONCLUSIONS
Based on experience and review of the literature, this
author would answer the initial questions as follows:
How should we initiate labour analgesia?: Use a CSE
because it provides reliable, fast analgesia with low doses
of analgesic drugs and improves the effectiveness of your
epidural catheter.
How should we maintain analgesia?: PCEA is the
way forward.
Which local anaesthetic should we use? Probably, but
still controversial, either ropivacaine or levobupivacaine
because the possibility of less motor block.
Which adjuvant drugs?: Opioids, both epidurally and
intrathecally, certainly whilst epidural clonidine and
neostigmine are good candidates which need further
study.
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